Skip to main content
. 2020 Feb 7;18(2):210–218. doi: 10.5217/ir.2019.00091

Table 5.

Comparison between Patients with and without Upper GI Symptoms

Characteristic Asymptomatic (n=9) Symptomatic (n=10) P-valuea
Baseline characteristics
 Sex 0.65
  Male 6 (66.7) 5 (50.0)
  Female 3 (33.3) 5 (50.0)
 Nationality 0.58
  Saudi 8 (88.9) 7 (70.0)
  Non Saudi 1 (11.1) 3 (30.0)
 Parental consanguinity 0.58
  Yes 8 (88.9) 7 (70.0)
  No 1 (11.1) 3 (30.0)
Montreal classification
 Age group 0.23
  A1 (< 17 yr) 6 (66.7) 3 (30.0)
  A2 (17–40 yr) 3 (33.3) 6 (60.0)
  A3 (> 40 yr) 0 1 (10.0)
 Location 0.25
  L1 (Terminal ileal) 7 (77.8) 4 (40.0)
  L2 (Colonic) 1 (11.1) 3 (30.0)
  L3 (Ileo-colonic) 1 (11.1) 3 (30.0)
 Behavior 0.37
  B1 (Non-stricturing & non-penetrating) 8 (88.9) 9 (90.0)
  B2 (Stricturing) 0 1 (10.0)
  B3 (Penetrating) 1 (11.1) 0
Endoscopy findings
 Esophageal 0.62
  Normal 8 (88.9) 8 (80.0)
  Aphthous ulcers 1 (11.1) 1 (10.0)
  Stricture 0 1 (10.0)
 Gastric 0.32
  Normal 3 (33.3) 0
  Erythema 2 (22.2) 3 (30.0)
  Erosions 3 (33.3) 5 (50.0)
  Aphthous ulcers 1 (11.1) 1 (10.0)
  Stricture 0 1 (10.0)
 Duodenal 0.34
  Normal 6 (66.7) 6 (60.0)
  Erythema 3 (33.3) 2 (20.0)
  Aphthous ulcers 0 2 (20.0)
Histopathological findings
 Esophageal 0.78
  Normal 4 (44.4) 6 (60.0)
  Chronic active duodenitis 4 (44.4) 3 (30.0)
  Focal chronic active duodenitis 1 (11.1) 1 (10.0)
 Gastric 0.71
  Normal 2 (22.2) 1 (10.0)
  Chronic active gastritis 4 (44.4) 6 (60.0)
  Focal enhanced gastritis 3 (33.3) 3 (30.0)
 Duodenal 0.62
  Normal 8 (88.9) 8 (80.0)
  Aphthous ulcers 1 (11.1) 1 (10.0)
  Stricture 0 1 (10.0)

Values are presented as number (%).

a

Fisher exact test.